Sam-A Pharm. Co., Ltd (KOSDAQ:009300)

South Korea · Delayed Price · Currency is KRW

13,020

+90 (0.70%)

At close: Nov 13, 2026

Market Cap	79.47B -22.3%
Revenue (ttm)	72.28B -12.4%
Net Income	10.55B -31.3%
EPS	1,727.22 -31.3%
Shares Out	6.10M
PE Ratio	7.54
Forward PE	n/a
Dividend	850.00 (6.53%)
Ex-Dividend Date	Dec 29, 2026

Volume	1,928
Open	12,930
Previous Close	12,930
Day's Range	12,900 - 13,070
52-Week Range	11,950 - 17,130
Beta	0.31
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 20, 2026

About Sam-A Pharm.

Sam-A Pharm. Co., Ltd operates as a pharmaceutical company in South Korea. The company offers a range of pharmaceutical products in the areas of respiratory, antibiotics, anti-virals, anti-histamines, anti-fungals, dermatology, pain/inflammation, gastrointestinal, cardiovascular, metabolism, urological, and steroids, as well as psychotropic agents; and OTC products in the areas of respiratory, ant-analgesics, gastro-intestinal, topical, oral, and anti-histamines. It provides NOMA MEGAFFECT for stress relief, eye care, memory and blood lipid con... [Read more]

Industry Pharmaceutical Preparations

Founded 1945

Employees 313

Stock Exchange KOSDAQ

Ticker Symbol 009300

Full Company Profile

Financial Performance

In 2025, Sam-A Pharm.'s revenue was 77.80 billion, a decrease of -18.60% compared to the previous year's 95.58 billion. Earnings were 12.94 billion, a decrease of -41.39%.

Financial Statements